Pulmonx 

Yahoo Finance • last month

Pulmonx to Participate in September Investor Conferences

REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at t... Full story

Yahoo Finance • 2 months ago

Discover the top movers in Thursday's pre-market session.

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMME... Full story

Yahoo Finance • 2 months ago

Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns

Investing.com - Piper Sandler downgraded Pulmonx Corp . (NASDAQ:LUNG) from Overweight to Neutral on Thursday, while significantly reducing its price target to $2.50 from $9.00 following the company’s second-quarter report. The stock, whic... Full story

Yahoo Finance • 2 months ago

Pulmonx revises 2025 revenue target to $90M–$92M as U.S. initiatives ramp slower, while international growth accelerates

Earnings Call Insights: Pulmonx Corporation (LUNG) Q2 2025 MANAGEMENT VIEW * Steven S. Williamson, CEO, highlighted second quarter 2025 revenue of $23.9 million and emphasized international performance, stating, "Our international busi... Full story

Yahoo Finance • 2 months ago

Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains

Pulmonx Corp reported its Q2 2025 earnings, revealing a net loss of $0.38 per share, slightly better than the forecasted loss of $0.40. The company recorded revenue of $23.9 million, surpassing expectations of $23.47 million. Following the... Full story

Yahoo Finance • 2 months ago

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at... Full story

Yahoo Finance • 3 months ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

REDWOOD CITY, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial re... Full story

Yahoo Finance • 4 months ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at... Full story

Yahoo Finance • 6 months ago

Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025

REDWOOD CITY, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fi... Full story

Yahoo Finance • 8 months ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth q... Full story

Yahoo Finance • 8 months ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fires... Full story

Yahoo Finance • 8 months ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

REDWOOD CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fou... Full story

Yahoo Finance • 2 years ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fires... Full story

Yahoo Finance • 2 years ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

REDWOOD CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the thi... Full story

Yahoo Finance • 2 years ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Derrick Sung steps down from his position as Chief Financial Officer to pursue another opportunity; John McKune appointed Interim Chief Financial OfficerPreliminary, unaudited third quarter 2023 revenue expected to be approximately $17.6 m... Full story

Yahoo Finance • 2 years ago

Pulmonx to Participate at Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in two upc... Full story

Yahoo Finance • 2 years ago

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

REDWOOD CITY, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the sec... Full story

Yahoo Finance • 3 years ago

Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth q... Full story

Yahoo Finance • 3 years ago

Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference

REDWOOD CITY, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fire... Full story

Yahoo Finance • 3 years ago

Pulmonx Reports Third Quarter 2022 Financial Results

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the third qu... Full story